Home/Filings/4/0001209191-20-038667
4//SEC Filing

O'Connell Daniel P 4

Accession 0001209191-20-038667

CIK 0001664106other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 8:00 PM ET

Size

8.0 KB

Accession

0001209191-20-038667

Insider Transaction Report

Form 4
Period: 2020-06-19
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-19+10,00010,000 total
    Exercise: $7.96Exp: 2030-06-19Common Stock (10,000 underlying)
  • Award

    Restricted Stock Units

    2020-06-19+2,5132,513 total
    Common Stock (2,513 underlying)
Footnotes (3)
  • [F1]All of the options will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of LogicBio Therapeutics, Inc. (the "Company") 2021 Annual Meeting of Stockholders, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan (the "2018 Plan").
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
  • [F3]All of the RSUs will vest on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan.

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother

Related Parties

1
  • filerCIK 0001752965

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:00 PM ET
Size
8.0 KB